36 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
to the minority interest in such Subsidiary) and (f) any gains or losses (less all fees and expenses chargeable thereto) attributable to any sales
424B3
0iglrnpnfianteflcv72
16 Mar 07
Prospectus supplement
12:00am
DEFM14A
kj2tmmfy
24 Jan 07
Proxy related to merger
12:00am
PRER14A
n6nmcieqg3u6iw
14 Dec 06
Preliminary revised proxy
12:00am
PREM14A
t36gdao5bt2ikot9h pw
6 Nov 06
Preliminary proxy related to merger
12:00am
POS AM
398qqf6f1 2kvxva8
12 Apr 06
Prospectus update (post-effective amendment)
12:00am
PREN14A
y8kxe67hz4 xqcyw
9 Nov 05
Preliminary proxy statement filed by non-management
12:00am